BayStar Capital Funds
From Wikipedia, the free encyclopedia
The LRG Capital Funds (formerly BayStar Capital Funds) are managed by LRG Capital Group, LLC. The BayStar Capital III Investment Fund [1](BayStar Capital III) is a multi-strategy investment fund that makes direct investments in small-to mid capitalization, public and late-stage private companies, primarily within the technology and life sciences sectors. Driven by Alpha–based absolute returns, the Fund provides complete transparency to its investors.
LRG Capital Group is a global investment, banking and advisory boutique that focuses on public and private companies in the technology, life sciences, hospitality, real estate and entertainment sectors. Founded by Lawrence (Larry) R. Goldfarb, the firm provides capital via private equity investing, commercial loans and structured debt financing, and guides clients on mergers and acquisitions, corporate finance advice and other strategic alternatives. Headquartered in San Francisco, with offices in New York and Miami, LRG Capital Group excels at relationship-focused guidance and financing.
Contents |
[edit] Investments
The BayStar Capital III Investment Fund invests in public companies[2] (such as Glasshouse Technologies, Inc.[3] and Virtualscopics[4]) that have a long term viable business model, an experienced management team and possess a major market opportunity.
Prior BayStar Capital Funds have collectively invested over $1.5 billion of equity in more than 250 companies[5].
[edit] BayStar Investments In The Press
BayStar III Fund Investment GlassHouse enters strategic partnership with Dell [1]
BayStar Capital III Fund Investment GlassHouse Technologies[2] Plans IPO [3]
Baystar Capital III Investment Fund, L.P. Invests in Virtualscopics[4], a Premier Provider of Next Generation Imaging Solutions to the Biotechnology and Pharmaceutical Industries [5]
BayStar Capital III Investment Fund, L.P. agrees to provide up to $16 Million to GlassHouse Technologies, Inc. [6]
[edit] LRG Capital In The Press
LRG Capital, Signature Prep Emerging Market Fund[7]
Admiral Joins LRG Capital in New Hedge Fund[8]
LRG Capital Group Adds Multi-Strategy Hedge Fund to Platform Through Partnership With Admiral Capital Management, LLC [9]
FIRST Robotics Teams Sponsored by LRG Capital Group Win Awards at Regional Competition[10]
Lawrence Goldfarb Speaks About FIRST on Comcast Newsmakers [11]
Q&A with LRG Hospitality Advisory Shah Bahreyni [12]
LRG Capital Group Names Shah Bahreyni as Managing Director of Newly Formed Hospitality Group [13]
LRG Capital Group Expands Its Corporate Advisory Group With the Addition of Kimberly T. Lynch [14]
LRG Capital Group Makes Second Investment in Japan’s Arque Orion Group[15]. [16]
LRG Capital Group Celebrates Inaugural Year Highlighted by Successful and Diverse Transactions, and Growing Team [17]
LRG Advisory Selected to Advise Zilog on Acquisition [18]
LRG Capital Group Sponsors "Dylan Interpreted" at the Mill Valley Film Festival. [19]
Lawrence R. Goldfarb spoke at BAS Ventures, Inc. Institutional Investor and Consultant Roundtable “The Changing Investment Paradigm: Merging Traditional and Alternative Assets” on the topic of “What’s next in private equities?” [20] [21]
LRG Capital Group Appoints Heather C. Ross Managing Director of Sales and Marketing [22]
Island Global Yachting Featured on CNBC's "High Net Worth" Segment [23]
LRG Capital Makes Additional Investment in OM Records [24]
LRG sponsors Dean Kamen’s visit to Marin County, California to establish a FIRST program for the North Bay [25].
LRG Capital’s CEO, Lawrence R. Goldfarb, to contribute to definitive new book on investing in biotechnology venture capitals [26] [27].
[edit] Philanthropy
LRG Capital Group’s philanthropy consists of donating finances, resources, and time to various organizations including, but not limited to:
- Ambassadors of Hope and Opportunity [28] [29]
- Blue Bear School of American Music [30] [31]
- The Lower EastSide Girls Club of New York [32] [33]
- FIRST [34] [35] [36]
- Room to Read [37]
- The Ryder Foundation[38][39]
- Scleroderma Research Foundation [40][41]
- Drug Policy Alliance [42]
